Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Inflammation Research
Published in: Inflammation Research 12/2013

Open Access 01-12-2013 | Original Research Paper

Tonic stimulation of the pharyngeal mucosa causes pain and a reversible increase of inflammatory mediators

Authors: Bertold Renner, Gabi Ahne, Elke Grosan, Birgit Kettenmann, Gerd Kobal, Adrian Shephard

Published in: Inflammation Research | Issue 12/2013

Login to get access

Abstract

Objective and design

To develop a model of the inflammatory component of non-infectious sore throat using tonic stimulation and quantification of inflammatory mediators in pharyngeal lavage fluid.

Material or subjects

Forty-five healthy volunteers.

Treatment

Cold dry air.

Method

Tonic stimulation of the pharynx was achieved using a constant stream of cold dry air to the back of the throat. Following optimization of stimulation conditions (phase 1), pharyngeal pain, irritation, and swallowing discomfort were assessed using visual analog scales, and the concentration of inflammatory markers were measured in pharyngeal lavage fluid (phase 2).

Results

Optimum conditions for tonic pharyngeal stimulation were cold dry air at 12 °C, relative humidity 20 %, at a flow rate of 12 L/min for 15 min. Analysis of pharyngeal lavage fluid collected 5 min after stimulation showed significant increases in prostaglandin E2 (P = 0.018), thromboxane B2 (P < 0.001), and substance P (P < 0.001), but no increase in peptidoleukotriene. When the stimulus was removed, the level of inflammatory markers in pharyngeal lavage fluid returned to baseline by 30 min post-stimulation. These objective measures mirrored subjective pain ratings.

Conclusions

Tonic stimulation of the pharyngeal mucosa with cold dry air causes pain and an increase of inflammatory mediators which are reversible.
Appendix
Available only for authorised users
Literature
1.
Renner B, Mueller CA, Shephard A. Environmental and non-infectious factors in the aetiology of pharyngitis (sore throat). Inflamm Res. 2012;61:1041–52.PubMedCrossRef
2.
Bedard PM, Jobin M, Clement L, Mourad W, Hebert J. Evaluation of nonspecific nasal reactivity to histamine during and after natural ragweed pollen exposure. Am J Rhinol. 1989;3:211–5.CrossRef
3.
Bascom R, Kagey-Sobotka A, Proud D. Effect of intranasal capsaicin on symptoms and mediator release. J Pharmacol Exp Ther. 1991;259:1323–7.PubMed
4.
Borum P. Nasal methacholine challenge. A test for the measurement of nasal reactivity. J Allergy Clin Immunol. 1979;63:253–7.PubMedCrossRef
5.
Philip G, Togias AG. Nonallergic rhinitis. Pathophysiology and models for study. Eur Arch Otorhinolaryngol. 1995;252(Suppl 1):S27–32.PubMedCrossRef
6.
Proud D, Reynolds CJ, Lacapra S, Kagey-Sobotka A, Lichtenstein LM, Naclerio RM. Nasal provocation with bradykinin induces symptoms of rhinitis and a sore throat. Am Rev Respir Dis. 1988;137:613–6.PubMedCrossRef
7.
Schachtel BP, Fillingim JM, Thoden WR, Lane AC, Baybutt RI. Sore throat pain in the evaluation of mild analgesics. Clin Pharmacol Ther. 1988;44:704–11.PubMedCrossRef
8.
Schachtel BP, Pan S, Kohles JD, Sanner KM, Schachtel EP, Bey M. Utility and sensitivity of the sore throat pain model: results of a randomized controlled trial on the COX-2 selective inhibitor valdecoxib. J Clin Pharmacol. 2007;47:860–70.PubMedCrossRef
9.
Lötsch J, Ahne G, Kunder J, Kobal G, Hummel T. Factors affecting pain intensity in a pain model based upon tonic intranasal stimulation in humans. Inflamm Res. 1998;47:446–50.PubMedCrossRef
10.
Mohammadian P, Schaefer D, Hummel T, Kobal G. Experimentally induced nasal irritation. Rhinology. 1999;37:175–8.PubMed
11.
Koren HS, Hatch GE, Graham DE. Nasal lavage as a tool in assessing acute inflammation in response to inhaled pollutants. Toxicology. 1990;60:15–25.PubMedCrossRef
12.
Hummel T, Huber H, Menzel S, Kobal G. Tonic versus phasic pain: dose-related effects of ketoprofen. Eur J Clin Pharmacol. 1995;49:7–14.PubMedCrossRef
13.
Kobal G, Hummel C, Gruber M, Geisslinger G, Hummel T. Dose-related effects of ibuprofen on pain-related potentials. Br J Clin Pharmacol. 1994;37:445–52.PubMedCrossRef
14.
Lötsch J, Mohammadian P, Hummel T, Florin S, Brune K, Geisslinger G, Kobal G. Effects of azapropazone on pain-related brain activity in human subjects. Br J Clin Pharmacol. 1995;40:545–52.PubMedCrossRef
15.
Renner B, Clarke G, Grattan T, Beisel A, Mueller C, Werner U, Kobal G, Brune K. Caffeine accelerates absorption and enhances the analgesic effect of acetaminophen. J Clin Pharmacol. 2007;47:715–26.PubMedCrossRef
16.
Hauber HP, Rüller S, Müller E, Hansen E, Zabel P. Pharyngeal lavage lymphocytosis in patients with obstructive sleep apnea: a preliminary observation. PLoS ONE. 2011;6:e16277.PubMedCrossRef
17.
Grosan E. Erzeugung eines Entzündungsschmerzes durch tonische Reizung der Rachenschleimhaut gesunder Probanden mit kalter, trockener Luft (Inducing inflammatory pain by tonic pharyngeal stimulation with cold dry air in healthy subjects). Thesis, Erlangen Germany: Friedrich-Alexander University Erlangen-Nuremberg; 2005.
18.
Kobal G, Hummel T. Olfactory evoked potentials in humans. In: Getchell TV, Doty RL, Bartoshuk LM, Snow JB, editors. Smell and taste in health and disease. New York: Raven Press; 1991.
19.
Kobal G, Hummel C, Nuernberg B, Brune K. Effects of pentazocine and acetylsalicylic acid on pain-rating, pain-related evoked potentials and vigilance in relationship to pharmacokinetic parameters. Agents Actions. 1990;29:342–59.PubMedCrossRef
20.
Hauser-Kronberger C, Hacker GW, Franz P, Albegger K, Dietze O. CGRP and substance P in intraepithelial neuronal structures of the human upper respiratory system. Regul Pept. 1997;72:79–85.PubMedCrossRef
21.
Beecher HK. Measurement of subjective responses: quantitative effects of drugs. New York: Oxford University Press; 1959.
22.
Togias AG, Naclerio RM, Proud D, Fish JE, Adkinson NF Jr, Kagey-Sobotka A, Norman PS, Lichtenstein LM. Nasal challenge with cold, dry air results in release of inflammatory mediators. Possible mast cell involvement. J Clin Invest. 1985;76:1375–81.PubMedCrossRef
23.
Patrignani P, Panara MR, Greco A, Fusco O, Natoli C, Lacobelli S, Cipollone F, Ganci A, Créminon C, Maclouf J, et al. Biochemical and pharmacological characterization of the cyclooxygenase activity of human blood prostaglandin endoperoxide synthases. J Pharmacol Exp Ther. 1994;271:1705–12.PubMed
24.
Togias AG, Naclerio RM, Peters SP, Nimmagadda I, Proud D, Kagey-Sobotka A, Adkinson NF Jr, Norman PS, Lichtenstein LM. Local generation of sulfidopeptide leukotrienes upon nasal provocation with cold, dry air. Am Rev Respir Dis. 1986;133:1133–7.PubMed
Metadata
Title
Tonic stimulation of the pharyngeal mucosa causes pain and a reversible increase of inflammatory mediators
Authors
Bertold Renner
Gabi Ahne
Elke Grosan
Birgit Kettenmann
Gerd Kobal
Adrian Shephard
Publication date
01-12-2013
Publisher
Springer Basel
Published in
Inflammation Research / Issue 12/2013
Print ISSN: 1023-3830
Electronic ISSN: 1420-908X
DOI
https://doi.org/10.1007/s00011-013-0663-7

Other articles of this Issue 12/2013

Inflammation Research 12/2013 Go to the issue

Original Research Paper

The effect of 7-ketocholesterol and 25-hydroxycholesterol on the integrity of the human aortic endothelial and intestinal epithelial barriers

Original Research Paper

Direct comparison of laser Doppler flowmetry and laser Doppler imaging for assessment of experimentally-induced inflammation in human skin

Original Research Paper

Inflammatory mediators of systemic inflammation in neonatal sepsis

Original Research Paper

Serum amyloid A, phospholipase A2-IIA and C-reactive protein as inflammatory biomarkers for prostate diseases

Original Research Paper

Docosahexaenoic acid reduces inflammation and joint destruction in mice with collagen-induced arthritis

Original Research Paper

Paeoniflorin inhibits inflammatory responses in mice with allergic contact dermatitis by regulating the balance between inflammatory and anti-inflammatory cytokines
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits